Search
for
Sort by
Research 211–240 of 1000+
- Skin-specific regulation of SREBP processing and lipid biosynthesis by glycerol kinase 5
- Attenuating 5α-pregnane-3α-ol-20-one formation in the hippocampus of female rats increases pentylenetetrazole-induced seizures
- Steroid Sulfatase Deficiency and Androgen Activation Before and After Puberty
- Female pattern hair loss in men: A distinct clinical variant of androgenetic alopecia
- Androgens and Parkinson’s disease: the role in humans and in experiment
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Hormonal manipulation of benign prostatic hyperplasia
- “Sebocytes’ makeup” - Novel mechanisms and concepts in the physiology of the human sebaceous glands
- Vitamin E-induced coagulopathy in a young patient: a case report
- Androgenetic alopecia: a review
- 5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes
- 5α-Reductase isozymes and aromatase mRNA levels in plucked hair from young women with female pattern hair loss
- Current understanding and treatment of sex hormone-related hair diseases
- Effect of finasteride on the ovulatory function of normal women
- Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- Development of Stratum Corneum Lipid Liposomes for Topical Drug Delivery
- Enhanced remyelination during late pregnancy: involvement of the GABAergic system
- Molecular Mechanisms and Therapeutic Advances in Androgenetic Alopecia
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Antiandrogen Therapy for Skin and Hair Disease
- ACNE
- Congenital adrenal hyperplasia
- Post-finasteride syndrome – does it really exist?
- Evaluation and treatment of male and female pattern hair loss
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation
- Identification of a new plant extract for androgenic alopecia treatment using a non-radioactive human hair dermal papilla cell-based assay
- Post-finasteride syndrome
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model